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Summary  
The use of patient-reported outcome measures (PROMs) is rising across all medical 
specialties as their importance to patient care is validated. They are likely to play a 
particularly important role in plastic and reconstructive surgery where outcomes are 
often subjective, and the recent guidance from the Royal College of Surgeons of 
England advising their use in cosmetic surgery highlight this. In order to drive their 
routine use across our specialty it is important that clinicians are able to understand 
the often complex and confusing language that surrounds their design and validation. 
In this article we describe the process of PROM design and validation, and attempt to 
‘demystify’ the language used in the health outcome literature. We present the 
important steps that a well-designed PROM must go through and suggest a 
straightforward guide for selecting the most appropriate PROMs for use in clinical 
practice. We hope that this will encourage greater use of PROM data across plastic 
and reconstructive surgery and ultimately help improve outcomes for our patients.  
 
 
 
 
Key Words: Patient-reported outcome measures; PROM; plastic surgery; 
reconstructive surgery; guide 
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Introduction  
 Patient reported outcome measures (PROMs) are standardised, validated 
questionnaires that are completed by patients and capture one or more aspects of their 
health and wellbeing
1,2
. In a world where shared-decision making between clinicians’ 
and patients’ is encouraged3, traditional measures of health outcomes have needed to 
change from traditional assessments conducted from the surgeon’s perspective (e.g., 
do we as the operating surgeon think that the patient has had a “good” outcome) to 
encompass a more holistic and patient-centred view. Moreover, the definition of 
health has evolved to include outcomes such as happiness, quality of life and the 
ability to perform tasks of daily living. This change is so important that the World 
Health Organisation (WHO) defines health as ‘a state of physical, mental and social 
well-being and not just the absence of disease or infirmity’4. PROMs are therefore 
designed to encompass and measure these aspects of health that can either not be 
directly observed or it is not feasible to observe
5
.  
 Many PROMs were originally developed for assessing treatment effectiveness 
in the context of clinical trials
7
. They are, however, becoming more commonly used 
in other situations, such as routine monitoring of treatment effect and health-care 
service provision. NHS England has orchestrated a national PROMs programme since 
2009, requiring routine collection of PROMs data for all those undergoing hip and 
knee replacement surgery, inguinal hernia surgery and varicose vein surgery
2,7
. More 
recently the Royal College of Surgeons of England advocated the routine collection of 
PROMs for a number of cosmetic procedures, using three prominent questionnaires, 
BREAST-Q
8
, FACE-Q
9
 and BODY-Q
10
.  
 There are a number of benefits to incorporating PROM data into research and 
routine clinical practice, especially in a specialty such as plastic and reconstructive 
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surgery where objective outcomes can be difficult to quantify. It is important that we 
have patient-reported data to advocate certain treatments for patients, especially in the 
current climate where rationing of procedures is occurring. Many regulatory bodies 
also demand the inclusion of patient-reported data in applications
11
. The drive for 
value-based healthcare requires the wider adoption of PROMs to measure health 
outcomes across different providers and healthcare settings
12,13 
and the King’s Fund 
report suggests that PROMs are likely to become “a key part of how health care is 
funded, provided and managed”2.  
 
Types of PROM 
 PROMs are typically classified as generic or disease-specific. Generic PROMs 
such as the EQ-5D, which is a measure of health status and SF-6D, which measures 
quality of life, are designed to be applied across different disease states
14
. These 
generic PROMs allow comparisons of quality of life across a wide range of 
conditions. Disease-specific (also known as condition-specific), are as the name 
indicates, specific to certain diseases or body areas. Unlike generic PROMs they are 
able to discriminate with greater sensitivity between individuals with specific 
conditions. A wide range of disease-specific PROMs are available in the plastic and 
reconstructive surgery literature (Table 1). PROMs are delivered in a questionnaire 
format, which can be administered in various ways, such as paper or computer based, 
or online platforms. Each question is usually scored on a Likert-type scale, with 
scores summed to give a total score for the underlying group of questions or 
‘construct’. In some instances, questions are given different weights based on their 
importance in contributing to the total score
15
. Typically, the PROM is applied at 
more than one time point during the patient pathway, allowing comparison of scores 
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(either from the same person or pooled scores from multiple patients), pre- and post-
intervention, or to evaluate changes in disease course.  
 
Assessing the quality of a PROM 
 Given the ever-expanding range of PROMs it is important that clinicians and 
researchers are able to appraise and choose the best PROMs for their needs. In 
choosing which PROM to use one needs to take into account its application (clinical 
versus research), the condition being investigated and the validity of the PROM. The 
‘validity’ is the extent to which a PROM measures what it intends to measure or what 
can be concluded about a patient’s health condition based on a particular score. There 
have been several publications in which standards for assessing specific 
measurements of a PROM have been discussed, including the scientific advisory 
committee of the Medical Outcome Trust
16
, Evaluating the Measurement of Patient-
Reported Outcomes (EMPRO) tool
17
, the Food and Drug Administration (FDA)
18
, 
McDowell and Jenkinson
19
, Bombardier and Tugwell
20
, Andresen
21
, Streiner
22
, 
DeVon et al
23
 and Terwee et al
24
. However, these publications are largely written for 
the health outcome specialist audience and are therefore complex and confusing for 
those not familiar with the literature and certain concepts are taken for granted. In 
order to encourage the use of PROMS in clinical practice and research, it would be 
beneficial for the process of design and validation to be understandable to clinicians.  
 This article builds on the recent publication in this journal by Wormald and 
Rodrigues
25
, demystifying the process of PROM development and validation required 
for a ‘good’ PROM. We present a guide to choosing which PROM to use (Figure 1) 
along with a practical assessment tool for clinicians to assess PROMs, allowing them 
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to pick the most appropriate and valid PROM for their condition or patient group of 
interest. 
 
Aspects of PROM design and validation 
 
Item selection 
 The first stage in any PROM development is to generate a pool of items that 
cover all aspects of the area of interest
27,27. ‘Items’ are the questions that will be 
included in the questionnaire and can be derived from five main sources: literature 
review; patients; clinical observations; expert opinion and generic item banks.  
 A literature review is the most common way to begin developing a PROM
27
. 
It aims to identify PROMs that have already been developed and used in the clinical 
area of interest, with the questions from these PROMs possibly used in the 
development of a new PROM or the adaptation of an existing one. This has obvious 
time efficiencies when using items that have already undergone construction and 
psychometric evaluation.  
 Patients are often the most useful source of item generation and inclusion of 
patients is considered by the FDA to be the most important source of item generation. 
Many well developed PROMs in plastic surgery follow this approach
28-30
.  
 Clinical observation is a particularly fruitful source of items, however in 
modern PROM development clinical observation should not be used alone. 
 Expert opinion is commonly employed to either generate items or comment on 
those that have already been suggested. However, as with patient-derived items, it is 
important to aim for a heterogeneous mix of individuals within the group to minimize 
bias when selecting questions for inclusion in a new PROM.  
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 Finally, items can be sourced from an item bank such as the Patient Reported 
Outcome Measurement Information System (PROMIS). They are sponsored by the 
National Institutes of Health in the United States to develop a standardized, validated 
item bank
31,32
. (http://www.nihpromis.com). 
 
Readability of items and cross-cultural adaptation   
Once the initial pool of items has been generated using a combination of the 
above methods, items should be checked for complex or technical language. Each 
question should also follow the US Department of Health and Human Services 
(USDHHS) recommendation for patient-orientated health literature and be written at 
or below the sixth-grade level, equating to a UK reading age of 11-12 years
33
. 
Furthermore, it is important to note that PROMs are language specific. That is, in 
order that the items are understandable and have the same meaning in a different 
language, they require translation and cross-cultural adaptation
34
, such as with the 
Spanish version of the Skin Cancer Index
35
.  
  
Item piloting   
Following the process of item generation, a PROM should be piloted in a 
group of patients to determine their face and content validity and to select those items 
that are most relevant.  
 Face validity refers to whether the questions appear to be assessing the desired 
qualities (i.e. are they on the surface measuring what they actually are) while content 
validity is concerned with whether the whole instrument (the entire questionnaire) is 
measuring all that is relevant and important to the patient and their condition
15
. The 
results of the piloted questions can then be subject to a number of statistical methods 
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to identify those items that are most relevant, which can then be taken forward for 
further psychometric evaluation. These initial items should be assessed for: 
 Frequency of endorsement: The frequency of endorsement is a measure of the 
proportion of people that give a different response to each item in the 
questionnaire. If items (questions) have a response that either has a lot of 
people or very few people answer the same way it will add little to the overall 
questionnaire and should be eliminated. In practice only those items with a 
frequency of endorsement between 0.2 and 0.8 (between 20% and 80% of 
people answering with the same response for an item) should be retained
27
. 
 Item-total correlation: Item-total correlation (also known as item-partial total 
correlation) is the correlation between the individual item and the total scale 
score omitting that item. Generally items that correlate below 0.3 and above 
0.7 should be considered for removal
36
 as this indicates they are either not 
relevant or redundant.   
 Internal consistency: Internal consistency is a measure of the homogeneity of 
a scale that contains multiple items (i.e., it assesses the extent to which each 
item is measuring the same concept)
15,24
. Two statistical measures for internal 
consistency are described, the Kuder-Richardson formula and Cronbach’s 
alpha
37,38, although Cronbach’s alpha is much more commonly used. Values 
for Cronbach’s alpha range between 0 and 1, with a value of >0.70 suggested 
as the minimum requirement for internal consistency
15
. An upper limit has 
also been suggested of 0.95, because above this, items correlate too closely 
and therefore there is redundancy in the scale
24
.  
 Factor analysis: Factors analysis is a statistical method used to explain the 
correlation between different variables and therefore the underlying structure 
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of the scale (i.e., the different aspects of the “latent” or underlying trait that the 
scale is purporting to measure). It allows the user to determine if the scale is 
unidimensional (i.e., measures a single attribute) and helps identify those 
items that are not contributing to the scale and therefore could be removed
39
. 
Two basic types of factor analysis exist, exploratory factor analysis (EFA) and 
confirmatory factor analysis (CFA). The type of factor analysis used depends 
on whether the PROM developers are seeking to reduce the number of items 
in a scale/ instrument or confirm its underlying structure
15
.  
 Principal component analysis: Principal component analysis (PCA) is similar 
to factor analysis in that it is a data reduction technique used to identify items 
that are redundant and therefore could be removed from a scale. Many people 
have argued over the difference between PCA and factor analysis, however, 
both are used in the health outcomes literature. Data from PCA is expressed as 
an eigenvector and an eigenvalue. According to Kaiser’s rule those factors 
with an eigenvalue values of 1 and above should be retained
40
. There will 
usually be more than one principal component (also known as uncorrelated 
variables), but the total number should be less than or equal to the number of 
original items and have therefore reduced the quantity of data. 
 
Reliability 
 Reliability refers to how consistent the results of a scale are when applied in 
different situations
41
. It reflects the amount of random and systematic error that is 
inherent in any measurement and results from the interaction of the instrument, the 
specific group using the instrument and the situation. Therefore it is not specifically 
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the reliability of the instrument per se but the reliability of the results obtained when 
the instrument is used in that particular manner
42
.  
 A reliability coefficient is calculated to illustrate the degree to which a PROM 
can differentiate between different patients. A number of different statistical methods 
exist for calculating the reliability coefficient, but the three most commonly seen in 
the literature are the Pearson correlation coefficient, the Intra-class correlation 
coefficient (ICC) and Kappa coefficient
15
. Scores are reported between one and zero, 
such that one equals perfect reliability and zero no reliability. There is little consensus 
on what the value of reliability should be, although it is commonly quoted that it 
should be greater than 0.70
43
, with some authors suggesting a coefficient of greater 
than 0.90 for clinical tools
15
. Whilst a higher reliability coefficient indicates the test is 
more reliable, if it is too close to 1 then this may suggest that important items 
reflecting the full scope of the condition in question have been omitted, thus reducing 
the usefulness of the questionnaire
44
.  
 Different forms of reliability are reported in the literature, usually dependent 
on the study design and type of questionnaire being assessed. Commonly used forms 
of reliability include: 
 Test-retest reliability is a measure of the reliability of the instrument over the 
passage of time. It is assessed by getting the same group of patients to answer 
the questionnaire at two time points, separated by an appropriate period of 
time, usually 2-14 days
15
. It is important that the condition of interest in the 
group used for test-retest reliability is not changed during this period.  
 Inter-observer reliability refers to the reliability of the scores between 
different observers (i.e., when two clinicians score the same patient at the 
same time the scores should be the same).  
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 Intra-observer reliability is the consistency of the instrument when the same 
individual is assessed by the same clinician on two separate occasions. Intra- 
and inter-observer reliability cannot be applied to those instruments that are 
self-administered. 
 Finally, parallel-forms reliability refers to how consistent the scores are when 
an individual takes two or more forms of the same questionnaire. It is used 
when comparing questionnaires that are thought to be assessing the same 
domains
15
.  
  
Validity  
 The validity of a health outcome measure refers to whether or not it is able to 
measure exactly what it is intended to measure and, therefore, can accurate 
conclusions about the presence and degree of the attribute be deduced? It is based on 
inference (e.g., a person who scores highly on a measure of distress would be 
expected to be more distressed than someone who doesn’t). Traditionally there have 
been three basic forms of validity
45
; content validity, criterion validity and construct 
validity, however further sub-types have been developed and may be reported in the 
literature.  
 Face validity is more commonly used as part of the item generation and 
reduction stage and has been described in more detail above.  
 Content validity is a judgment assessment of whether the items in a scale 
encompass all relevant and important areas of the concept being measured in 
appropriate detail
15
. This is commonly assessed by experts in the field and just 
reported in papers as having been carried out. More recently however there has been a 
drive to quantify the degree of content validity, with it being suggested that all 
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instrument development studies should report on the content validity assessment
46
. 
This may be documented in the form of a content validity index (CVI), where a total 
scale score of 0.90 or above is considered to be excellent content validity
47
.  
 Criterion validity compares the instrument under study to another measure of 
the subject of interest (ideally the ‘gold standard’) and assesses how well they 
correlate
15
. Two types of criterion validity are described: concurrent validity and 
predictive validity. Concurrent validity applies when the new scale and the ‘gold 
standard’ are administered at the same time. Correlation between the scores are 
typically assessed with a phi coefficient of Pearson correlation coefficient, a positive 
correlation being considered to be greater than 0.70. Predictive validity is performed 
when the outcome being measured occurs in the future and one is trying to determine 
if the new instrument is able to predict this future event and therefore give an answer 
earlier than the current instrument. In this case the new scale would be administered at 
time point 1 and then the old measure used at time point 2 in the future. Scores are 
then compared to see if the new measure is able to predict future outcomes
15
. 
  Construct validity is the term used to describe the relationships between 
various, non-measurable factors that combine to describe something we can observe. 
For example, anxiety is not an ‘observable’ trait, but the many symptoms and signs 
which we attribute to anxiety can be combined into a construct to represent anxiety 
which can be measured. Construct validity is therefore seen as an overarching term 
used to encompass all forms of validity and refers to how well a measure or 
questionnaire is able to assess the construct that it is trying to assess
15,48,49
. It is 
assessed by making hypotheses as to how this measure will correlate when assessed 
against other measures of the same construct. The hypotheses that are generated are 
either a positive correlation (termed convergent validity) or a negative correlation 
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(known as divergent validity). It is important that the hypotheses are stated in advance 
to avoid bias that may occur if hypotheses are developed retrospectively to fit the 
observed correlations between scales. Terwee et al specified that for a questionnaire 
to be rated as positive for construct validity, hypotheses should not only be specified 
in advance but that at least 75% of the results should agree with these hypotheses in a 
group of at least 50 patients
24
.  
 
Responsiveness and sensitivity  
 Responsiveness is defined as the ‘ability of an instrument to measure a 
clinically important change’ while sensitivity is the ‘ability of an instrument to 
measure any change regardless of whether it is clinically meaningful’50,51. Many 
variations on these definitions are described
52-54 
in the literature. Assessment of 
responsiveness should be based on hypothesis testing, in a similar manner to construct 
validity, with hypotheses made regarding the expected differences in change between 
‘known’ groups24. 
 Two broad approaches exist to test responsiveness, either anchor-based or 
distribution-based
55
. In an anchor-based approach the relationship between the change 
in the instrument score and an external variable (such as a patient-reported change in 
their condition or laboratory measurements) is measured. Statistical analysis of this 
involves measuring the area under curve (AUC)
56
, with a score of > 0.70 considered 
adequate
24
. Distribution-based methods are based on statistical characteristics of the 
sample. A wide range of statistical methods exist, but the most commonly reported 
include Cohen’s effect size15, Guyatt’s responsiveness ratio57 and the standardized 
response mean
58
.  
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Interpretability  
 Interpretability is closely related to responsiveness. In clinical practice a 
PROM that has all the required attributes above but does not have clinical meaning is 
potentially useless. Therefore, interpretability refers to the degree to which one can 
assign qualitative meaning to the quantitative score of the instrument
24,59
. To establish 
the interpretability of a PROM the minimal important difference (MID) also known as 
the minimal important change (MIC)
60
, standard error of measurement (SEM), and 
smallest detectable change (SDC) should be calculated. The MID is defined by 
Jaeschke et al as ‘the smallest difference in score in the domain of interest which 
patients perceive as beneficial and which would mandate in the absence of trouble-
some side-effects and excessive cost, a change in the patient’s management’61. It is 
recommended that the MID/MIC is defined by the study team and provide 
information as to what change in score would be considered to be clinically 
meaningful.  
 Assessing floor and ceiling effects can also be useful in helping to understand 
interpretability. The instrument is considered to have a floor or ceiling effect when 
15% of respondents achieve either the lowest or highest possible score respectively
24
. 
If a floor or ceiling effect exists it will leave those patients who score at the extremes 
with only one direction in which they can move on the scale and thus both the 
responsiveness and interpretability in these groups is diminished.  
 A glossary of terms used in PROM development and validation is presented in 
Table 2.  
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Classical Test Theory versus Modern Test Theory 
 So far we have presented the psychometric properties of classical test theory 
(CTT), the traditional and most commonly used technique for the development and 
validation of PROMs to date
62,63
. However, another more modern psychometric 
technique used in PROM development and validation is item response theory (IRT)
64
. 
This is being increasingly used to validate plastic surgery related PROMs, such as the 
‘Q-series’30. In CTT the underlying assumption is that the observed score is a 
combination of the true score plus a degree of random error and that because the 
random error is normally distributed the expected value of all random errors equals 
zero
65
. This leads to a number of problems, such as the established psychometric 
properties only relate to the specific population and situation in which the 
questionnaire was developed, the assumption that all items in the scale contribute 
equally to the final score and difficulty with equating scores that someone achieves on 
different tests
15,66
. IRT aims to overcome these issues by focusing on individual items 
in the questionnaire rather than the overall or test-level score. It assumes that all items 
are measuring the same underlying construct, but that individual items have different 
weights and therefore do not contribute equally to the final score. IRT uses the 
principle of latent traits (as discussed above in factor analysis) and log odds units 
(Logits) to allow the creation of an interval scale. This allows the final scale to be 
truly used to determine if a patients’ condition has changed and by what degree15.   
 IRT is an over-riding term given to a number of different statistical methods, 
one of which being Rasch measurement theory (RMT)
67
. For more information on the 
difference between IRT and Rasch please see Cano and Hobart, 2011
66
. Many of the 
concepts described above for the development and validation of a PROM are the same 
whether CTT or IRT is used. Items still need to be developed and reduced using 
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techniques such as exploratory and confirmatory factor analysis, which at the same 
time confirms whether there is unidimensionality in the items (meaning all items are 
measuring the same underlying construct and an assumption that is key to IRT). 
Further statistical testing to determine local independence (items are independent of 
one another and the answer to one does not depend on the answer to another) and item 
fit provides evidence that the instrument is both valid and reliable. When using Rasch 
analysis the Person Separation Index should be calculated to aid in the determination 
of reliability
15,68
. 
 As a result of IRT assessing item-level psychometrics, questionnaires 
developed using IRT can be used in a process called adaptive testing. In CTT the 
questionnaire is generally only deemed valid and reliable if all items are administered, 
however with adaptive testing different subsets of items are given to different patients 
based on their answers to preceding items, usually facilitated by a computer 
programme and termed computerized adaptive testing (CAT). Overall questionnaire 
scores can still be compared between individuals and this approach has the advantage 
of ‘tailoring’ the questionnaire to the patient, therefore reducing the responder 
burden
25,68
.   
 Many consider IRT to now be the ‘gold standard’ technique for developing 
and validating a PROM. Despite this there are drawbacks to its use, such as requiring 
larger sample sizes, added expertise in the study team and consequently greater 
development costs
68
. Furthermore, strict assumptions in the model can mean that 
items may be rejected even when they have good content validity if they do not fit the 
IRT model. CTT should therefore not be disregarded and many argue that it has a role 
to play in the validation process alongside IRT. Furthermore, it is likely that when 
reviewing the current literature clinicians will more commonly encounter the 
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principles of CTT, given that many currently used PROMs were developed a number 
of years ago. The quality checklist proposed below therefore incorporates both CTT 
and elements of IRT.  
 
Quality checklist 
 We propose the use of a simple checklist (Table 3) when appraising a PROM, 
which covers the five most important aspects of its design and validity testing: 1) item 
generation, 2) reliability, 3) validity, 4) responsiveness and 5) interpretability. This is 
an adaption from Alrubaiy et al.
69
. 
 
Discussion 
 With the increasing use of PROMs in research and clinical practice it is 
important that clinicians understand their development, validation and use. Without 
this understanding they will be at a loss when involved in clinical studies, appraising 
research papers and asked to collect patient-reported outcomes data in their routine 
clinical practice. This paper has been written to help the practicing plastic and 
reconstructive surgeon understand the main components that make up the design and 
validation of a good quality PROM. We have also included a simplified assessment 
checklist, which can be used when appraising different PROMs and aid in decision 
making as to which one to use.  
 Choosing the right PROM to use is very important, particularly given their 
increased use in routine clinical practice
70
. They must be psychometrically valid
18
 and 
clinically meaningful. The fact that many questionnaires are too long and 
cumbersome, disincentivising patients from completing them
71
 lends further weight to 
the importance of understanding the criteria of a good-quality PROM. Future efforts 
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in the design of new PROMs (or the adaptation of old ones) need to focus on making 
simple, but still clinically meaningful and discriminatory PROMs. Further advances 
will be made in PROM development and validation by improving the ease and speed 
of completion and data collection and synthesis through the use of web or tablet-based 
platforms
72
. Integration of PROM data with other outcome measures will increase the 
power of big data outputs in plastic surgery, driving innovation and improving patient 
care. 
 This paper is not meant to be a detailed description of all aspects of PROM 
design and validation as there are many other excellent resources that cover this. We 
hope that through highlighting the important areas of a validated PROM, plastic 
surgeons will feel more comfortable in appraising a PROM for its appropriateness for 
their needs and the quality of its development and validation. We hope that this 
practical guidance will not only increase the quality of PROMs used, but will also 
increase uptake of their use in routine clinical practice. We all want what is best for 
our patients’ and by asking for their opinion on their condition and treatment 
outcomes it is hoped that plastic and reconstructive surgery will continue to improve 
those aspects of patients’ lives that matter most to them. 
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Figure 1: A step-by-step guide demonstrating the steps to be carried out in deciding 
on and implementing a patient-reported outcome measure (PROM) into ones clinical 
or research practice.  
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Table 1: A selection of condition-specific patient-reported outcome measures 
(PROMs) designed for use in the plastic and reconstructive surgery community. This 
is not an exhaustive list, but designed to indicate the broad spectrum of PROMs 
available in our specialty.  
Sub-specialty Example of condition-specific PROM 
Burns CBOQ: Children Burn Outcome 
Questionnaire 
Breast BREAST-Q™ 
Cleft CLEFT-Q™ 
Cosmetic FACE-Q™ 
BODY-Q™ 
Hand DASH: Disabilities of the Arm, Shoulder 
and Hand score 
Michigan Hand Outcome Questionnaire 
Head and Neck NOSE: Nasal Obstruction and 
Septoplasty Effectiveness scale 
EORTC QLQ-H&N43: European 
Organisation for Research and Treatment 
of Cancer Head and Neck Module 
Lower Limb TESS: Toronto Extremity Salvage Score 
Skin Cancer SCI: Skin Cancer Index 
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Table 2: Glossary of terms commonly used in patient-reported outcome measure 
(PROM) development and psychometric validation. 
Term Definition 
Classical Test Theory The traditional method of assessing the scientific 
robustness of a PROM. 
Content validity Refers to whether the whole instrument is measuring 
all that is relevant and important to the patient and 
their condition.  
Criterion validity Assessment of how well the instrument being studied 
correlates with another instrument (ideally considered 
to be the gold-standard). 
Face validity A subjective measure of whether the questions are 
actually measuring what they are meant to be.  
Instrument A method of capturing data. In the case of patient-
reported outcome measures an instrument usually 
refers to a questionnaire.  
Items An item is an individual question. Multiple items make 
up an instrument. 
Interpretability The degree to which one can assign clinical meaning to 
the quantitative score given by an instrument. 
Modern Test Theory Rasch measurement theory and item response theory 
and two methods encompassed by the term ‘modern 
test theory’. These are newer methods of statistical 
analysis, designed to address some of the flaws of 
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classical test theory. 
Patient-reported 
outcome measures 
Standardised and validated questionnaires that are 
designed to capture one or more aspect of a person’s 
health and wellbeing. 
Reliability Refers to how consistent the results are when the 
instrument is applied in different situations.  
Responsiveness Refers to the ability of an instrument to measure a 
clinically important change. 
Sensitivity Refers to the ability of an instrument to measure any 
change.  
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Table 3: A simplified checklist for evaluating a patient-reported outcome measure 
(PROM). 
Area of assessment Individual component Was it 
performed?  
In those studies that 
applied Item 
Response Theory 
(IRT) models 
- Was the IRT model used appropriately 
described? 
- Was the statistics package used adequately 
described e.g. RUMM2020, WINSTEP etc? 
- Was an adequate method of estimation used? 
- Were the assumptions of unidimensionality, 
local independence and item fit checked? 
 
Item generation - Were the items sourced appropriately? 
- Was the target population included in item 
generation? 
- Was face validity assessed? 
- Frequency of endorsement calculated (0.2-
0.8) 
- Item-total correlation calculated (0.3-0.7) 
- Internal consistency calculated (Cronbach’s 
Alpha 0.7-0.95) 
 
Reliability - Was a reliability co-efficient calculated and 
was it >0.7? 
- Was a measure of test-retest/inter-
observer/intra-observer/parallel-forms 
reliability calculated? 
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* Person Separation Index > 0.7, to be able to 
differentiate between 2 groups of people   
Responsiveness Was responsiveness assessed?  
If so was an appropriate method used (e.g. 
area under curve >0.7, Cohen’s effect size 
>0.8, Guyatt’s responsiveness ratio >0.5) 
 
Construct Validity - Was construct or criterion validity assessed? 
- Were a priori hypotheses stated? 
*Was a test determining the unidimensionality 
of the scale performed? 
*Chi-square values summarizing the 
difference between observed and expected 
responses 
 
Interpretability - Are the results clinically relevant? 
- Was a floor-to-ceiling effect calculated? 
- Was a minimally important difference 
(MID), standard error of measurement (SEM) 
and smallest detectable change (SDC) 
calculated? 
 
Burden - Was there some assessment of the degree of 
burden placed on the patient completing the 
PROM? 
 
The first box is used to determine if the paper uses Item Reponses Theory (IRT) or 
Classical Test Theory (CTT). If CTT is used none of the first 4 questions can be 
answered.  
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* denotes areas in which IRT papers will quote differing test statistics to CTT.  
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